Stay updated on Pembrolizumab in Hypermutation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Hypermutation Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.3 to v3.5.4, signaling a new version of the page template or platform rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-05-15T05:10:52.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.5.2 to v3.5.3, signaling a newer version of the page content. This change reflects a minor metadata update rather than alterations to study details.
    Difference
    0.0%
    Check dated 2026-04-30T18:53:59.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Minor version update from v3.5.0 to v3.5.2 with no visible changes to study details or on-page content.
    Difference
    0.0%
    Check dated 2026-04-16T11:10:59.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-18T20:27:33.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.4.3 released. The page content appears unchanged aside from the version label.
    Difference
    0.0%
    Check dated 2026-03-11T17:36:12.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Results have been posted for the study, including ORR, PFS, and OS outcomes with posting dates. The page now includes links to the study protocol and statistical analysis plan.
    Difference
    3%
    Check dated 2026-03-04T13:39:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Hypermutation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.